The impact of VEN on OS or EFS did not differ in NPM1 mutated AML compared to wild-type (HR: 1.04, CI: 0.24-4.52 P=0.96), (HR: 0.91, CI: 0.42-1.95, P=0.9). This evidence concerns the gene NPM1 and acute myeloid leukemia.